- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | MariMed Inc.: MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers | 1 | GlobeNewswire (USA) | ||
| 15.07. | Marimed Inc: Marimed to release Q2 results Aug. 12 | 2 | Stockwatch | ||
| 15.07. | MariMed Inc.: MariMed Announces Second Quarter 2026 Earnings Date | 1 | GlobeNewswire (USA) | ||
| MARIMED Aktie jetzt für 0€ handeln | |||||
| 14.07. | Marimed Inc: Marimed rolls out Betty's Bite-A-Mins | 1 | Stockwatch | ||
| 14.07. | MariMed Inc.: MariMed's Betty's Eddies Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins | 1 | GlobeNewswire (USA) | ||
| 26.06. | Marimed Inc: Marimed applies to register for state-licensed ops | 2 | Stockwatch | ||
| 25.06. | MariMed Inc.: MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses | 90 | GlobeNewswire (Europe) | NORWOOD, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator, today announced the Company has submitted... ► Artikel lesen | |
| 08.06. | MARIMED INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | MARIMED INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.05. | MariMed forecasts licensing revenue early next year while planning Ohio store opening before year-end | 2 | Seeking Alpha | ||
| 14.05. | MariMed Q1 2026 Earnings Call: Complete Transcript | 2 | Benzinga.com | ||
| 13.05. | MARIMED INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 13.05. | MariMed GAAP EPS of -$0.01 in-line, revenue of $39.48M beats by $0.73M | 1 | Seeking Alpha | ||
| 13.05. | MariMed Inc.: MariMed Reports First Quarter 2026 Earnings | 179 | GlobeNewswire (Europe) | NORWOOD, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day,... ► Artikel lesen | |
| 16.04. | Marimed Inc: Marimed to release Q1 results May 13 | 1 | Stockwatch | ||
| 15.04. | MariMed Inc.: MariMed Announces First Quarter 2026 Earnings Date | 2 | GlobeNewswire (USA) | ||
| 12.03. | MARIMED INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 12.03. | MariMed outlines 2026 growth strategy as wholesale revenue rises 11% and new state expansions advance | 5 | Seeking Alpha | ||
| 11.03. | MariMed Non-GAAP EPS of $2.20 beats by $2.21, revenue of $41.7M beats by $0.9M | 3 | Seeking Alpha | ||
| 11.03. | MariMed Inc.: MariMed Reports Fourth Quarter and Full Year 2025 Earnings | 246 | GlobeNewswire (Europe) | NORWOOD, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day... ► Artikel lesen |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,598 | +0,93 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2027 First Quarter Results | NASDAQ | TSX: ACB
Delivers Net Revenue of $67.6 million, including a 17% YoY Increase in International Medical Cannabis Net Revenue
Safari Flower Company Receives Three-Year EU-GMP... ► Artikel lesen | |
| ABBVIE | 212,00 | -0,33 % | AbbVie: Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX Cosmetic for Masseter Muscle Prominence | If approved, BOTOX® Cosmetic (onabotulinumtoxinA) would be the only neurotoxin with five aesthetic indications and the first and only approved for masseter muscle... ► Artikel lesen | |
| CANOPY GROWTH | 0,841 | -0,10 % | Canopy Growth übertrifft Gewinnerwartungen für Q1 2027 - Aktie legt zu | ||
| TILRAY BRANDS | 3,955 | +0,13 % | Tilray-Aktie: Startet jetzt die 700%-Chance? | Die Tilray-Aktie hat in den vergangenen Tagen eine bemerkenswerte Kehrtwende vollzogen. Nach enttäuschenden Quartalszahlen am 28. Juli geriet der Cannabis-Titel zunächst unter Druck, ehe bereits einen... ► Artikel lesen | |
| INNOCAN PHARMA | 1,500 | +0,67 % | Innocan Pharma Corporation: Over 100,000 Positive Verified Customer Reviews Reflect Growing Consumer Trust | Milestone underscores strong consumer confidence, exceptional product quality, and the Company's expanding presence in the U.S. consumer wellness marketHERZLIYA, Israel and CALGARY, Alberta... ► Artikel lesen | |
| DERMAPHARM | 40,500 | -0,86 % | dpa-AFX-Überblick: UNTERNEHMEN vom 17.07.2026 - 15.15 Uhr | ROUNDUP: SMA wird erneut optimistischer für 2026 - Aktie springt hoch NIESTETAL - Der Photovoltaik-Spezialist SMA Solar hat im zweiten Quartal nach vorläufigen Berechnungen besser abgeschnitten als... ► Artikel lesen | |
| CRONOS GROUP | 2,646 | -1,19 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| SYNBIOTIC | 1,106 | +2,98 % | EQS-Adhoc: SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung von Insolvenzverfahren zu stellen | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Strategische Unternehmensentscheidung/Insolvenz
SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung... ► Artikel lesen | |
| DIGICANN VENTURES | 0,012 | +118,18 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,864 | +1,77 % | Organigram Global Inc: Organigram Global to release fiscal Q3 results Aug. 11 | ||
| GREEN THUMB INDUSTRIES | 5,870 | -1,68 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,057 | -0,19 % | SNDL: Produktionsstätte in New Brunswick besteht EU-GMP-Audit | ||
| CRESCO LABS | 0,621 | -3,72 % | Cresco Labs Q2 2026 slides: cannabis re-rating thesis meets skepticism | ||
| NOVERIS HEALTH SCIENCES | 0,292 | -9,88 % | Noveris Health Sciences Inc.: Noveris Health Sciences Inc. Unaware of Any Material Change | Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - At the request of CIRO, Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") wishes... ► Artikel lesen |
MARIMED INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MARIMED INC finden Sie auf Wallstreet Online.